Filing Details
- Accession Number:
- 0001019687-10-000261
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-21 12:00:00
- Reporting Period:
- 2010-01-19
- Filing Date:
- 2010-01-21
- Accepted Time:
- 2010-01-21 20:33:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1282393 | Bioform Medical Inc | BFRM | Surgical & Medical Instruments & Apparatus (3841) | 391979642 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227036 | Biotechnology Development Fund Iv Lp | 575 High Street, Suite 201 Palo Alto, CA 94301 | No | No | Yes | No | |
1261786 | Bioasia Investments Iv Llc | 575 High Street, Suite 201 Palo Alto, CA 94301 | No | No | Yes | No | |
1416946 | Bioasia Crossover Fund Lp | 575 High Street, Suite 201 Palo Alto, CA 94301 | No | No | Yes | No | |
1417304 | Biotechnology Development Fund Iv Affiliates Lp | 575 High Street, Suite 201 Palo Alto, CA 94301 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-01-19 | 3,669 | $5.51 | 22,347 | No | 4 | S | Indirect | By Biotechnology Development Fund IV Affiliates, L.P. |
Common Stock | Disposition | 2010-01-19 | 198,487 | $5.51 | 1,209,057 | No | 4 | S | Indirect | By Biotechnology Development Fund IV, L.P. |
Common Stock | Disposition | 2010-01-19 | 58,182 | $5.51 | 354,406 | No | 4 | S | Indirect | By BioAsia Crossover Fund, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Biotechnology Development Fund IV Affiliates, L.P. |
No | 4 | S | Indirect | By Biotechnology Development Fund IV, L.P. |
No | 4 | S | Indirect | By BioAsia Crossover Fund, L.P. |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The reported securities are owned directly by Biotechnology Development Fund IV Affiliates, L.P. and indirectly by BioAsia Investments IV, LLC, as general partner of Biotechnology Development Fund IV Affiliates, L.P. BioAsia Investments IV, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
- The reported securities are owned directly by Biotechnology Development Fund IV, L.P. and indirectly by BioAsia Investments IV, LLC, as general partner of Biotechnology Development Fund IV, L.P. BioAsia Investments IV, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
- The reported securities are owned directly by BioAsia Crossover Fund, L.P. and indirectly by BioAsia Investments IV, LLC, as general partner of BioAsia Crossover Fund, L.P. BioAsia Investments IV, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.